Navigation Links
Actavis Receives Approval of Alprazolam ODT in the U.S.
Date:3/17/2010

MORRISTOWN, N.J., March 17 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets. Distribution of the product will commence immediately.  

"We're very pleased to add Alprazolam ODT to our portfolio and complete our Alprazolam family of offerings, which also includes Alprazolam extended-release and immediate release tablets," said Actavis Inc. CEO Doug Boothe.  

Alprazolam ODT, the generic equivalent of Niravam®, will be available in 0.25 mg, 0.5 mg, 1.0 mg, and 2.0 mg strengths. Alprazolam orally disintegrating tablets are indicated for the management of anxiety disorder or the short-term relief of symptoms of anxiety. U.S. sales of Niravam® and generic equivalents totaled $12.4 million for the 12 months ending December 2009, according to IMS Health data.

About Actavis Inc.


'/>"/>
SOURCE Actavis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
(Date:1/15/2014)... Ill. , Jan. 15, 2014 The Cadence ... Medical Fitness Center by the Medical Fitness Association, a ... to achieve their full potential. The Cadence Fitness & ... the western suburbs and second in the Chicagoland area. ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... ATLANTA, Nov. 28, 2011   CardioMEMS, Inc ., an ... commercializing a proprietary wireless sensing and communication technology for ... CEO, Jay Yadav, M.D. , has been recognized ... Endeavor Awards in the Technology Entrepreneur category. The awards ...
... (NYSE Amex: PIP ), a biodefense company ... today that Eric I. Richman, President and Chief Executive ... Healthcare Conference being held November 29-30, 2011.  ... in one-on-one meetings at the conference.Event : , ...
Cached Medicine Technology:TechAmerica and the Technology Association of Georgia Name Dr. Jay Yadav, CardioMEMS Founder & CEO as a Spirit of Endeavor Award Finalist 2TechAmerica and the Technology Association of Georgia Name Dr. Jay Yadav, CardioMEMS Founder & CEO as a Spirit of Endeavor Award Finalist 3PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011 2
(Date:4/17/2014)... TORONTO, April 17, 2014 Giving patients adrenaline after they ... not increase their prospects of surviving long-term, according to ... vast number of patients who have a cardiac arrest ... treating cardiac arrest for decades," said Dr. Steve Lin, ... Michael,s. "Yet, despite advances in medical treatment, long-term survival ...
(Date:4/16/2014)... 15, 2014 The Translational Genomics Research Institute (TGen) ... Founders Dinner for their support of TGen,s research into ... March 28 in Scottsdale. , Catherine Ivy, Founder and ... TGen,s John S. McCain Leadership Award, named for U.S. ...
(Date:4/15/2014)... pre-diabetes in the United States have nearly doubled since 1988, ... Public Health, with obesity apparently to blame for the surge. ... has not hit all groups equally, with alarming increases in ... new research reported in the April 15, 2014 issue of ...
(Date:4/14/2014)... over the past decade, but targeting drugs to cancer ... major challenge. , Nanotechnology has unlocked new pathways ... or capsules, that can transport cargoes of small-molecule therapeutics ... These carriers are tiny, and it matters just how ...
(Date:4/14/2014)... IL A new study shows that moderate to severe obstructive ... cancer and death. , Results of the 20-year follow-up study show ... times more likely to die (hazard ratio = 4.2), nearly four ... times more likely to die from cancer (HR = 3.4), and ...
Breaking Medicine News(10 mins):Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Nano shake-up 2Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2
... Awareness of Lupus and ... Funds for Lupus Foundation of America, WASHINGTON, Sept. 13 ... Houston, Texas, two recent,college graduates, will end their 15 week ... 4,000 miles from Bellingham,Washington to Charleston, South Carolina. The ...
... Novelli as MDMA,s Director of Federal Affairs, ... (MDMA) is pleased to announce the appointment of,Thomas ... Affairs., (Photo: http://www.newscom.com/cgi-bin/prnh/20041004/MDMALOGO ), ... Senate Committee on Finance,for Senator Charles Grassley from ...
... explores industry trends and the utilization of ... 13 Visiprise, Inc., a leader in,manufacturing execution ... the company will host a series of podcast ... Titled "Operational,Efficiency in Medical Device Manufacturing," these free, ...
... SAN DIEGO, Sept. 13 NuVasive, Inc. (Nasdaq:,NUVA), ... for,minimally disruptive surgical treatments for the spine, announced ... and Kevin,O,Boyle, Executive Vice President and Chief Financial ... 5th Annual Growth,Conference at the St. Regis Hotel, ...
... China,Shenghuo Pharmaceutical Holdings, Inc. ("China Shenghuo," "the ... in the research, development, manufacture,and marketing of ... People,s Republic of China ("PRC"), today announced ... Chinese herbal skin care,products ("12Ways") on Sunday, ...
... Education Council raises awareness about prostate cancer ... and related health concerns, ... he,has prostate cancer -- the second-leading cause of cancer death in ... making prostate,cancer among men more prevalent than breast cancer among women. ...
Cached Medicine News:Health News:Bike Ride Across the U.S. to End Saturday at Folly Beach 2Health News:MDMA Names New Director of Federal Affairs 2Health News:Visiprise Launches Podcast Series with AMR to Support Medical Device Manufacturers 2Health News:NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference 2Health News:NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 2Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 4Health News:Prostate Cancer Awareness Week to Screen Thousands 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: